Evidence Based Medicine
Interested in literature review and evidence based medicine? We review both novel research as well as previous landmark studies in EM/CC in order to keep you up to date.
Interested in literature review and evidence based medicine? We review both novel research as well as previous landmark studies in EM/CC in order to keep you up to date.
Follow our Read collection for up to date literature of note. Updated twice a month.
EBM POSTS
The presentation is complicated by the fact that symptoms commonly associated with pulmonary embolisms in the non-pregnant population can be caused by normal physiologic changes of pregnancy.
“Cross-clamping” the aorta from the inside. That’s Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA).
A significant amount of data has slowly been trickling into the surgical literature that in many of the cases of appendicitis, rushing the gurney to the OR may not actually be what is best for the patient. This is where non operative treatment of acute appendicitis (NOTA) is born.
TXA, a derivative of lysine, works by blocking binding sites on plasminogen, inhibiting plasminogen’s conversion to plasmin, which can potentially inhibit trauma-induced coagulopathy caused by fibrinolysis.
The debate on what threshold to transfuse RBCs continues to burden many ICU intensivists, mainly with the question being posed, 'Why are we transfusing?'
We decided to take a look at a fairly recent article on one new therapy in modern resuscitation management, vasopressin-steroids-epinephrine (VSE) for in-hospital cardiac arrest. Have a look at what's changing and what is on the horizon and review the the literature for yourself below.
Turns out the central line may not be all that magical. Resuscitate early and adequately. Definitely one of the landmark trials to be well read on, so feast your heart out boys and girls.
This new study directly addresses this, with "high-risk diagnoses with potential complications" as a primary outcome along with radiation exposure and total costs. Maybe closer to our bottom line, rates of adverse events in general were comparable between groups.